{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T04:04:57Z","timestamp":1792037097884,"version":"4.4.0"},"reference-count":39,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2019,1,29]],"date-time":"2019-01-29T00:00:00Z","timestamp":1548720000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0211354","type":"journal-article","created":{"date-parts":[[2019,1,29]],"date-time":"2019-01-29T19:10:42Z","timestamp":1548789042000},"page":"e0211354","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":13,"title":["Epidemiology and factors associated with peripheral neuropathy among HIV infected patients in Gondar, Ethiopia: A cross-sectional study"],"prefix":"10.1371","volume":"14","author":[{"given":"Kedir Sany","family":"Adem","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3866-9351","authenticated-orcid":true,"given":"Balamurugan","family":"Janakiraman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berihu Fisseha","family":"Gebremeskel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mulugeta Bayisa","family":"Chala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asmare Yitayeh","family":"Gelaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kassahun","family":"Alemu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2019,1,29]]},"reference":[{"issue":"6","key":"ref1","first-page":"557","article-title":"Peripheral neuropathy in ART-experienced patients: prevalence and risk factors","volume":"19","author":"H. Chen","year":"2013"},{"key":"ref2","unstructured":"J. U. N. P. on HIV\/AIDS, UNAIDS Report on the global AIDS epidemic. December 2013. 2013."},{"key":"ref3","unstructured":"Colvin M, Gorgens-Albino M, Kasedde S. Analysis of HIV prevention response and modes of HIV transmission: the UNAIDS-GAMET-supported synthesis process. ND. <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.unaidsrstesa.org\/files\/MoT_0.pdf\" xlink:type=\"simple\">http:\/\/www.unaidsrstesa.org\/files\/MoT_0.pdf<\/ext-link> (last accessed 20 October 2010). 2008."},{"key":"ref4","first-page":"51","article-title":"HIV and peripheral neuropathy","author":"N. C. Chai","year":"2016"},{"issue":"5","key":"ref5","first-page":"816","article-title":"Sensory neuropathy in human immunodeficiency virus\/acquired immunodeficiency syndrome patients: Protease inhibitor\u2013mediated neurotoxicity","volume":"59","author":"J. A. Pettersen","year":"2006"},{"issue":"5","key":"ref6","first-page":"428","article-title":"HIV peripheral neuropathy progression: protection with glucose-lowering drugs?","volume":"18","author":"S. R. Evans","year":"2012"},{"issue":"1","key":"ref7","first-page":"16","article-title":"Peripheral Sensory Neuropathy and associated factors among adult diabetes mellitus patients in Bahr Dar, Ethiopia","volume":"16","author":"G. Jember","year":"2017"},{"issue":"3","key":"ref8","first-page":"479","article-title":"Bilateral object exploration training to improve the hand function in stroke subjects","volume":"2","author":"J. Balamurugan","year":"2013"},{"issue":"2","key":"ref9","first-page":"113","article-title":"Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain","volume":"10","author":"R. Chou","year":"2009"},{"issue":"24","key":"ref10","first-page":"2305","article-title":"Controlled trial of high-concentration capsaicin patch for treatment of painful HIV neuropathy","volume":"70","author":"D. M. Simpson","year":"2008"},{"issue":"2","key":"ref11","first-page":"85","article-title":"Opioid Prescriptions for Chronic Pain and OverdoseA Cohort Study","volume":"152","author":"K. M. Dunn","year":"2010"},{"issue":"4","key":"ref12","first-page":"477","article-title":"Opioids and HIV\/HCV infection","volume":"6","author":"X. Wang","year":"2011"},{"issue":"7","key":"ref13","first-page":"e0131353","article-title":"Trends in AIDS deaths, new infections and ART coverage in the top 30 countries with the highest AIDS mortality burden; 1990\u20132013","volume":"10","author":"R. Granich","year":"2015"},{"issue":"1","key":"ref14","first-page":"5","article-title":"Neurological complications associated with HIV and AIDS: clinical implications for nursing","volume":"45","author":"N. Theroux","year":"2013"},{"issue":"2","key":"ref15","first-page":"88","article-title":"Peripheral neuropathy and quality of life of adults living with HIV\/AIDS in the Rulindo district of Rwanda","volume":"9","author":"J. Biraguma","year":"2012"},{"issue":"5","key":"ref16","first-page":"485","article-title":"Peripheral neuropathy in HIV-infected and uninfected patients in Rakai, Uganda","volume":"89","author":"D. Saylor","year":"2017"},{"issue":"1","key":"ref17","first-page":"104","article-title":"Peripheral neuropathy in HIV patients in sub-Saharan Africa failing first-line therapy and the response to second-line ART in the EARNEST trial","volume":"22","author":"A. Arenas-Pinto","year":"2016"},{"issue":"1","key":"ref18","first-page":"3","article-title":"Prevalence and factors associated with use of khat: a survey of patients entering HIV treatment programs in Ethiopia","volume":"12","author":"A. R. Lifson","year":"2017"},{"key":"ref19","first-page":"341","article-title":"Diagnostic utility of the subjective peripheral neuropathy screen in HIV-infected persons with peripheral sensory polyneuropathy","author":"A. B. Venkataramana","year":"2005"},{"issue":"11","key":"ref20","first-page":"1778","article-title":"Evaluation of a clinical screening tool for HIV-associated sensory neuropathies","volume":"65","author":"C. L. Cherry","year":"2005"},{"issue":"3","key":"ref21","first-page":"565","article-title":"Implementation of a validated peripheral neuropathy screening tool in patients receiving antiretroviral therapy in Mombasa, Kenya","volume":"83","author":"S. A. Mehta","year":"2010"},{"key":"ref22","unstructured":"\u201cEthiopia:Analytical summary\u2014HIV\/AIDS\u2014AHO.\u201d [Online]. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.aho.afro.who.int\/profiles_information\/index.php\/Ethiopia:Analytical_summary_-_HIV\/AIDS\" xlink:type=\"simple\">http:\/\/www.aho.afro.who.int\/profiles_information\/index.php\/Ethiopia:Analytical_summary_-_HIV\/AIDS<\/ext-link>. [Accessed: 20-Nov-2017]."},{"issue":"1","key":"ref23","first-page":"244","article-title":"A longitudinal study of stavudine-associated toxicities in a large cohort of South African HIV infected subjects","volume":"11","author":"C. N. Menezes","year":"2011"},{"issue":"3","key":"ref24","first-page":"247","article-title":"Adverse drug reactions to antiretroviral therapy (ART): an experience of spontaneous reporting and intensive monitoring from ART centre in India","volume":"19","author":"R. R. Modayil","year":"2010"},{"issue":"3","key":"ref25","first-page":"304","article-title":"Antiretroviral durability and tolerability in HIV-infected adults living in urban Kenya","volume":"45","author":"C. Hawkins","year":"2007"},{"issue":"1","key":"ref26","first-page":"67","article-title":"Antiretroviral therapy using zidovudine, lamivudine, and efavirenz in South Africa: tolerability and clinical events","volume":"22","author":"C. J. Hoffmann","year":"2008"},{"issue":"2","key":"ref27","first-page":"85","article-title":"Assessment of the prevalence of distal symmetrical polyneuropathy and its risk factors among HAART-treated and untreated HIV infected individuals.","volume":"48","author":"J. S. Shurie","year":"2010"},{"key":"ref28","unstructured":"W. H. Organization, \u201cWHO case definitions of HIV for surveillance and revised clinical staging and immunological classification of HIV-related disease in adults and children,\u201d 2007."},{"key":"ref29","article-title":"Sampling Techniques","author":"W. G. Cochran","year":"1977"},{"issue":"8","key":"ref30","first-page":"1245","article-title":"A comparison of goodness of fit tests for the logistic GEE model","volume":"24","author":"S. Evans","year":"2005"},{"issue":"4","key":"ref31","first-page":"315","article-title":"Age and height predict neuropathy risk in patients with HIV prescribed stavudine","volume":"73","author":"C. L. Cherry","year":"2009"},{"issue":"7","key":"ref32","first-page":"919","article-title":"Peripheral neuropathy in HIV: prevalence and risk factors","volume":"25","author":"S. R. Evans","year":"2011"},{"issue":"7","key":"ref33","first-page":"467","article-title":"Distal sensory polyneuropathy in HIV-positive patients in the HAART era: an entity underestimated by clinical examination","volume":"17","author":"E. E. Skopelitis","year":"2006"},{"issue":"1","key":"ref34","first-page":"35","article-title":"HIV-associated sensory neuropathy in HIV-1 infected patients at the Douala General Hospital in Cameroon: a cross-sectional study","volume":"9","author":"H. N. Luma","year":"2012"},{"key":"ref35","article-title":"Influence of age and neurotoxic HAART use on frequency of HIV sensory neuropathy","volume":"2012","author":"O. Oshinaike","year":"2012"},{"issue":"10","key":"ref36","first-page":"1291","article-title":"High prevalence of distal sensory polyneuropathy in antiretroviral\u2010treated and untreated people with HIV in Tanzania","volume":"16","author":"S. Mullin","year":"2011"},{"issue":"3","key":"ref37","first-page":"226","article-title":"HIV-associated sensory neuropathy: risk factors and genetics","volume":"16","author":"P. R. Kamerman","year":"2012"},{"issue":"4","key":"ref38","first-page":"700","article-title":"HIV neuropathy risk factors and symptom characterization in stavudine-exposed South Africans","volume":"41","author":"A. L. Wadley","year":"2011"},{"issue":"1","key":"ref39","first-page":"148","article-title":"Modification of the incidence of drug-associated symmetrical peripheral neuropathy by host and disease factors in the HIV outpatient study cohort","volume":"40","author":"K. A. Lichtenstein","year":"2005"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0211354","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T14:24:43Z","timestamp":1589034283000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0211354"}},"subtitle":[],"editor":[{"given":"Marcel","family":"Yotebieng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,1,29]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,1,29]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0211354","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,29]]}}}